Registry-listed formulations

Hetastarch · mesh:M0010761

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

4 source entries across 4 studies. This list may not include all unresolved or historical entries.

  • HextendRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • 6% hetastarchRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • HextendRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • HextendRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
60%(3 trials)
Terminated
1(17%)

Phase Distribution

Not Applicable
1
17%
Phase 4
1
17%
Phase 3
3
50%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
3(60.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Terminated(1)

Detailed Status

Completed5
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 33 (60.0%)
Phase 41 (20.0%)
N/A1 (20.0%)

Trials by Status

terminated117%
completed583%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_4

A Comparison of Eleview Versus Hetastarch as Injectate for EMR

NCT03350217
completed

Use of Hextend in Trauma

NCT00983281
terminatedphase_3

Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI)

NCT00796419
completednot_applicable

Effects of Colloid and Crystalloid on the Microcirculatory Alterations During Off-pump Coronary Artery Bypass Surgery

NCT01713166
completedphase_3

An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy

NCT00467922
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT03350217Phase 4

A Comparison of Eleview Versus Hetastarch as Injectate for EMR

Completed
NCT00983281

Use of Hextend in Trauma

Completed
NCT00796419Phase 3

Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI)

Terminated
NCT01713166Not Applicable

Effects of Colloid and Crystalloid on the Microcirculatory Alterations During Off-pump Coronary Artery Bypass Surgery

Completed
NCT00467922Phase 3

An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy

Completed
NCT00307138Phase 3

Hetastarch and Bleeding Complications After Off-Pump Coronary Bypass Surgery

Completed

All 6 trials loaded

Drug Details

Intervention Type
Drug
Total Trials
6

Names & Codes

Trade Names

hespanhextend